BioProcess Container (BPC) Companies and Developments

Date : 18 September 2025

The bioprocess container (BPC) market is expected to grow from USD 5.54 billion in 2025 to USD 35.67 billion by 2034, at a CAGR of 23% between 2025 and 2034. Bioprocess containers help laboratory technicians easily transfer fluid media across research facilities and store them safely in cleanrooms whenever needed.

Top BioProcess Container Companies Globally

BioProcess Container (BPC) Packaging Market Top Key Players

Tier 1

  • Sartorius Stedim Biotech
  • Thermo Fisher Scientific
  • Merck Millipore (MilliporeSigma / Merck KGaA)
  • Cytiva
  • Pall Corporation (Danaher)
  • Corning Incorporated
  • 3M Company
  • GEA Group
  • Becton, Dickinson and Company (BD)
  • Lonza Group
  • Catalent plc
  • West Pharmaceutical Services
  • SCHOTT AG
  • Gerresheimer AG
  • Stevanato Group
  • Amcor plc
  • Berry Global Group, Inc.

Tier 2

  • Parker Hannifin Corporation
  • Saint-Gobain Performance Plastics
  • Fresenius Kabi
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Terumo Corporation
  • Repligen Corporation
  • Eppendorf AG / Eppendorf SE
  • WuXi Biologics / WuXi AppTec
  • Aptar Pharma / AptarGroup
  • Bio-Rad Laboratories

Tier 3

  • DWK Life Sciences
  • Nelipak Healthcare
  • Origin Pharma Packaging
  • Sonoco
  • Huhtamaki
  • Distek, Inc.
  • Emerson

Latest Announcements By Industry Leader

  • In September 2024, TekniPlex Healthcare, which uses high-level material science expertise to assist perfect patient results, will give importance to its expertise and intellectual property linked to single-use bioprocessing cell and gene therapy at CPI Milan, which took place between 8 and 10 October.

Recent Developments

  • In August 2025, Rotzinger Pharmapack is introducing the latest filling and capping stage for the aim of over-the-counter (OTC) products such as non-aseptic pharmaceuticals, as well as liquid and solid items from the personal care, cosmetics, and nutraceutical industries.